Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Anxiety and depression symptoms disrupt resting state connectivity in patients with genetic generalized epilepsies.

Garcia DDS, Polydoro MS, Alvim MKM, Ishikawa A, Moreira JCV, Nogueira MH, Zanão TA, de Campos BM, Betting LEGG, Cendes F, Yasuda CL.

Epilepsia. 2019 Apr;60(4):679-688. doi: 10.1111/epi.14687. Epub 2019 Mar 10.

PMID:
30854641
2.

Normal cerebral cortical thickness in first-degree relatives of temporal lobe epilepsy patients.

Alhusaini S, Kowalczyk MA, Yasuda CL, Semmelroch MK, Katsurayama M, Zabin M, Zanão T, Nogueira MH, Alvim MKM, Ferraz VR, Tsai MH, Fitzsimons M, Lopes-Cendes I, Doherty CP, Cavalleri GL, Cendes F, Jackson GD, Delanty N.

Neurology. 2019 Jan 22;92(4):e351-e358. doi: 10.1212/WNL.0000000000006834. Epub 2018 Dec 26.

PMID:
30587513
3.

ATP Synthase Subunit Beta Immunostaining is Reduced in the Sclerotic Hippocampus of Epilepsy Patients.

Mota MVB, Zaidan BC, do Canto AM, Ghizoni E, Tedeschi H, de Souza Queiroz L, Alvim MKM, Cendes F, Lopes-Cendes I, Schenka AA, Vieira AS, Rogerio F.

Cell Mol Neurobiol. 2019 Jan;39(1):149-160. doi: 10.1007/s10571-018-0641-2. Epub 2018 Dec 11.

PMID:
30539418
4.

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.

Paudel YN, Shaikh MF, Chakraborti A, Kumari Y, Aledo-Serrano Á, Aleksovska K, Alvim MKM, Othman I.

Front Neurosci. 2018 Sep 11;12:628. doi: 10.3389/fnins.2018.00628. eCollection 2018. Review.

5.

Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.

Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM.

Brain. 2018 Feb 1;141(2):391-408. doi: 10.1093/brain/awx341.

6.

Is inpatient ictal video-electroencephalographic monitoring mandatory in mesial temporal lobe epilepsy with unilateral hippocampal sclerosis? A prospective study.

Alvim MKM, Morita ME, Yasuda CL, Damasceno BP, Lopes TM, Coan AC, Ghizoni E, Tedeschi H, Cendes F.

Epilepsia. 2018 Feb;59(2):410-419. doi: 10.1111/epi.13977. Epub 2017 Dec 13.

7.

Sleep onset uncovers thalamic abnormalities in patients with idiopathic generalised epilepsy.

Bagshaw AP, Hale JR, Campos BM, Rollings DT, Wilson RS, Alvim MKM, Coan AC, Cendes F.

Neuroimage Clin. 2017 Jul 12;16:52-57. doi: 10.1016/j.nicl.2017.07.008. eCollection 2017.

8.

MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy.

Avansini SH, de Sousa Lima BP, Secolin R, Santos ML, Coan AC, Vieira AS, Torres FR, Carvalho BS, Alvim MK, Morita ME, Yasuda CL, Pimentel-Silva LR, Dogini DB, Rogerio F, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Apr 6;12(4):e0173060. doi: 10.1371/journal.pone.0173060. eCollection 2017.

9.

A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.

Silva-Alves MS, Secolin R, Carvalho BS, Yasuda CL, Bilevicius E, Alvim MK, Santos RO, Maurer-Morelli CV, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Jan 4;12(1):e0169214. doi: 10.1371/journal.pone.0169214. eCollection 2017.

10.

In response: Brain atrophy in seizure-free temporal lobe epilepsy: Implications for predicting pharmacoresistance.

Alvim MK, Coan AC, Yasuda CL, Morita ME, Cendes F.

Epilepsia. 2016 May;57(5):856-7. doi: 10.1111/epi.13379. No abstract available.

11.

Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy.

Alvim MK, Coan AC, Campos BM, Yasuda CL, Oliveira MC, Morita ME, Cendes F.

Epilepsia. 2016 Apr;57(4):621-9. doi: 10.1111/epi.13334. Epub 2016 Feb 11.

Supplemental Content

Loading ...
Support Center